Bafna Pharmaceuticals standalone net profit rises 88.89% in the December 2021 quarter

Sales rise 17.05% to Rs 20.46 crore
Net profit of Bafna Pharmaceuticals rose 88.89% to Rs 1.70 crore in the quarter ended December 2021 as against Rs 0.90 crore during the previous quarter ended December 2020. Sales rose 17.05% to Rs 20.46 crore in the quarter ended December 2021 as against Rs 17.48 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales20.4617.48 17 OPM %13.8312.64 -PBDT2.911.92 52 PBT1.700.90 89 NP1.700.90 89Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 10 2022 | 5:44 PM IST
